← Eichor
Condition: Drug Discontinuation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Drug Discontinuation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Phase 2 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06511882The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Phase 3 · 73 location(s) · American Society of Clinical Oncology · NCT06377852Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
Phase 1 · 1 location(s) · University of Illinois at Chicago · NCT05192122Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding R
NA · 18 location(s) · Samsung Medical Center · NCT06742931PRImary Care Strategies for Weight Management (PRISM) Study
NA · 1 location(s) · Rush University Medical Center · NCT07288294Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
NA · 1 location(s) · Erasmus Medical Center · NCT05652673Enhancing Hypnotic Medication Discontinuation in Primary Care
Phase 4 · 1 location(s) · National Jewish Health · NCT06435520Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation
NA · 1 location(s) · The University of Texas at Dallas · NCT07387796CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
NA · 1 location(s) · Baylor College of Medicine · NCT05609916
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.